Description

OMEZ DSR TAB (1X15)

Indications

OMEZ DSR TAB is primarily indicated for the treatment of various gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia. It is particularly useful in managing symptoms associated with excessive gastric acid secretion. The combination of its active ingredients helps to provide symptomatic relief and promotes healing of the gastric and duodenal mucosa.

Mechanism of Action

OMEZ DSR TAB contains a combination of Omeprazole and Domperidone. Omeprazole is a proton pump inhibitor (PPI) that works by irreversibly inhibiting the H+/K+ ATPase enzyme system at the surface of the gastric parietal cells. This inhibition leads to a significant reduction in gastric acid secretion, thereby alleviating symptoms of acid-related disorders. Domperidone, on the other hand, is a dopamine antagonist that enhances gastrointestinal motility. It works by blocking dopamine receptors in the gastrointestinal tract, which facilitates gastric emptying and reduces nausea and vomiting. The synergistic action of these two components makes OMEZ DSR TAB effective in treating conditions associated with both acid secretion and motility issues.

Pharmacological Properties

The pharmacokinetics of OMEZ DSR TAB is influenced by its active ingredients. Omeprazole is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 0.5 to 3.5 hours after administration. It has a high protein binding rate (approximately 95%) and is extensively metabolized in the liver. The elimination half-life of Omeprazole is approximately 1 hour, but its effects can last much longer due to the irreversible nature of its action on the proton pump.

Domperidone is also well-absorbed, with peak plasma concentrations reached within 1 to 2 hours. It has a bioavailability of approximately 15% due to first-pass metabolism. Domperidone is primarily excreted in the feces, and its half-life is about 7 to 9 hours. The pharmacological properties of both components contribute to the overall efficacy of OMEZ DSR TAB in managing gastrointestinal disorders.

Contraindications

OMEZ DSR TAB should not be used in patients with known hypersensitivity to Omeprazole, Domperidone, or any of the excipients in the formulation. It is contraindicated in individuals with a history of gastrointestinal bleeding, mechanical obstruction, or perforation. Additionally, patients with severe hepatic impairment or those taking concomitant medications that prolong the QT interval should avoid using this medication due to the risk of serious cardiac side effects.

Side Effects

Like any medication, OMEZ DSR TAB may cause side effects. Common adverse effects include headache, dizziness, dry mouth, and gastrointestinal disturbances such as diarrhea, constipation, and abdominal pain. Rare but serious side effects may include cardiac arrhythmias, especially in patients with pre-existing heart conditions. Long-term use of PPIs like Omeprazole has been associated with an increased risk of Clostridium difficile infection in the colon, bone fractures, and renal issues. Patients should be monitored for any unusual symptoms and report them to their healthcare provider promptly.

Dosage and Administration

The recommended dosage of OMEZ DSR TAB is typically one tablet taken orally before meals, preferably in the morning. The duration of therapy may vary depending on the condition being treated. For GERD and peptic ulcers, treatment may last for several weeks to months, while for dyspepsia, a shorter course may be sufficient. It is crucial to follow the prescribing physician’s instructions regarding dosage and duration to ensure optimal therapeutic outcomes.

Interactions

OMEZ DSR TAB may interact with several medications, which can affect its efficacy or increase the risk of side effects. Omeprazole can reduce the absorption of drugs that require an acidic environment for optimal bioavailability, such as ketoconazole and atazanavir. Additionally, it may enhance the effects of warfarin and other anticoagulants, necessitating close monitoring of coagulation parameters. Domperidone may interact with drugs that affect the QT interval, such as certain antipsychotics and antiarrhythmics. It is essential for patients to inform their healthcare provider about all medications they are taking to avoid potential interactions.

Precautions

Patients should exercise caution when using OMEZ DSR TAB if they have a history of liver disease, heart problems, or electrolyte imbalances. It is advisable to avoid using this medication in pregnant or breastfeeding women unless specifically directed by a healthcare provider. Long-term use of PPIs should be regularly assessed to weigh the benefits against potential risks, particularly in older adults or those with multiple comorbidities. Regular follow-up appointments are recommended to monitor the patient’s response to therapy and adjust treatment as necessary.

Clinical Studies

Clinical studies have demonstrated the efficacy of OMEZ DSR TAB in managing symptoms of GERD and peptic ulcers. A randomized controlled trial published in the Journal of Gastroenterology evaluated the combination of Omeprazole and Domperidone in patients with GERD. The results indicated a significant reduction in symptom severity and improvement in quality of life compared to placebo. Another study in the World Journal of Gastroenterology highlighted the role of Domperidone in enhancing gastric emptying and its synergistic effect with Omeprazole in patients with functional dyspepsia. These studies support the clinical use of OMEZ DSR TAB in treating acid-related gastrointestinal disorders.

Conclusion

OMEZ DSR TAB is a valuable therapeutic option for patients suffering from various gastrointestinal disorders characterized by excessive gastric acid secretion and motility issues. Its dual-action formulation provides effective symptom relief and promotes healing of the gastrointestinal mucosa. However, careful consideration of contraindications, potential side effects, and drug interactions is essential for safe and effective use. Patients should always consult with their healthcare provider to ensure that OMEZ DSR TAB is appropriate for their individual health needs.